Philip Mack, Ph.D.

Philip C. Mack, Ph.D.




Molecular Biology/Medicine


Internal Medicine


  • Director of Molecular Pharmacology
  • Professor


Clinical Interests

Dr. Mack conducts molecular biology and molecular pharmacology studies for the UC Davis Cancer Center, the California Cancer Consortium, and the Southwest Oncology Group. For the past twelve years, Dr. Mack has conducted basic and translational research, with an emphasis on lung cancer. His investigations include molecular and cellular effects of novel anticancer agents in lung cancer models. Dr. Mack is Director of the UC Davis Cancer Center Molecular Pharmacology shared resource, Director of Basic Sciences for the California Cancer Consortium and Associate Director of the Southwest Oncology Group Lung Translational Medicine Committee.


Hematology and Oncology


Ph.D., UC Davis, Davis, California, 1997

B.A., UC Santa Cruz, Santa Cruz, California, 1991

Professional Memberships

American Association for Cancer Research

American Society of Clinical Oncology

International Association for the Study of Lung Cancer

Southwest Oncology Group

Honors and Awards

Helen and Christine Landgraf Memorial Research Fund Award, 2002

Select Recent Publications

For a comprehensive list of Dr. Mack's publications, please click here (opens new window).